BlackRock Inc. Makes New Investment in LeMaitre Vascular, Inc. $LMAT

BlackRock Inc. purchased a new stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT) during the 2nd quarter, Holdings Channel reports. The fund purchased 3,272,973 shares of the medical instruments supplier’s stock, valued at approximately $314,075,000. BlackRock Inc. owned 0.14% of LeMaitre Vascular as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in LMAT. Sound Income Strategies LLC increased its stake in LeMaitre Vascular by 425.6% in the first quarter. Sound Income Strategies LLC now owns 226 shares of the medical instruments supplier’s stock valued at $25,000 after purchasing an additional 183 shares during the last quarter. Catalyst Capital Advisors LLC purchased a new stake in LeMaitre Vascular during the first quarter valued at about $32,000. Geneos Wealth Management Inc. increased its stake in LeMaitre Vascular by 250.3% during the first quarter. Geneos Wealth Management Inc. now owns 557 shares of the medical instruments supplier’s stock worth $47,000 after acquiring an additional 398 shares during the last quarter. EverSource Wealth Advisors LLC acquired a new position in shares of LeMaitre Vascular in the 2nd quarter valued at about $47,000. Finally, Quarry LP increased its position in LeMaitre Vascular by 267.2% during the 3rd quarter. Quarry LP now owns 727 shares of the medical instruments supplier’s stock worth $64,000 after purchasing an additional 529 shares in the last quarter. Hedge funds and other institutional investors own 84.64% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on the company. Weiss Ratings downgraded LeMaitre Vascular from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Friday, August 14th. Barrington Research downgraded shares of LeMaitre Vascular from an “outperform” rating to a “market perform” rating in a research report on Wednesday, August 5th. Citigroup reiterated a “market outperform” rating on shares of LeMaitre Vascular in a report on Tuesday, July 21st. Zacks Research cut LeMaitre Vascular from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 6th. Finally, Wall Street Zen downgraded shares of LeMaitre Vascular from a “buy” rating to a “hold” rating in a research report on Saturday, August 1st. Three investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat, LeMaitre Vascular has an average rating of “Hold” and a consensus target price of $110.60.

LeMaitre Vascular Stock Performance

Shares of LMAT stock opened at $79.61 on Thursday. The company has a market cap of $1.82 billion, a P/E ratio of 27.93, a PEG ratio of 2.28 and a beta of 0.53. LeMaitre Vascular, Inc. has a 52 week low of $78.27 and a 52 week high of $118.01. The company has a quick ratio of 13.96, a current ratio of 16.31 and a debt-to-equity ratio of 0.40. The business has a 50 day moving average of $93.60 and a two-hundred day moving average of $99.51.

LeMaitre Vascular (NASDAQ:LMAT) last issued its quarterly earnings data on Tuesday, August 4th. The medical instruments supplier reported $0.74 EPS for the quarter, missing analysts’ consensus estimates of $0.81 by ($0.07). The company had revenue of $70.38 million for the quarter, compared to the consensus estimate of $71.47 million. LeMaitre Vascular had a return on equity of 15.63% and a net margin of 25.02%.LeMaitre Vascular’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.60 earnings per share. As a group, analysts anticipate that LeMaitre Vascular, Inc. will post 2.89 EPS for the current year.

LeMaitre Vascular Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 3rd. Stockholders of record on Thursday, August 20th will be issued a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 1.3%. The ex-dividend date of this dividend is Thursday, August 20th. LeMaitre Vascular’s payout ratio is 35.09%.

LeMaitre Vascular Profile

LeMaitre Vascular, Inc is a specialty medical device company focused on the development, manufacture and marketing of products for the treatment of peripheral vascular disease. Headquartered in Burlington, Massachusetts, the company’s offerings include a broad portfolio of vascular surgical instruments, grafts, patches, catheters and embolic protection devices. LeMaitre’s product lines address key areas such as arterial reconstruction, endovascular repair and vascular access, serving the needs of cardiovascular surgeons and interventional specialists.

Founded in 1983 by George D.